Personalized Oral Maintenance Therapy with Decitabine/Cedazuridine (ASTX727) Combined with a Molecularly Targeted Agent (Venetoclax, Gilteritinib, Ivosidenib, or Enasidenib) in Acute Myeloid Leukemia in First Remission
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Alexandre Bazinet, Naval Daver, Farhad Ravandi, Nicholas J. Short, Musa Yilmaz, Maro Ohanian, Jo Ishizawa, Abhishek Maiti, Courtney D. DiNardo, Lucia Masarova, William G. Wierda, Kelly S. Chien, Elias Jabbour, Danielle Hammond, Fadi G. Haddad, Koji Sasaki, Alex Bataller, Debra Bull-Linderman, Gautam Borthakur, Guillermo Garcia-Manero, Hagop M. Kantarjian, Tapan M. Kadia
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405038686